What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Evidence to recommendation Framework: Bivalent COVID-19 vaccine booster doses
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Vaccines | Free Full-Text | Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
New Omicron-specific vaccines offer similar protection to existing boosters
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
:max_bytes(150000):strip_icc()/Booster-Shot-GettyImages-1362497127-e10ca9b1e3e5424db126022a8dc254bf.jpg "How Effective Are the Bivalent Boosters? CDC Shares New Data")
How Effective Are the Bivalent Boosters? CDC Shares New Data
CDC reports on bivalent COVID-19 vaccine, Paxlovid effectiveness | AHA News
A quick update on the bivalent boosters - by Eric Topol
Who Is Eligible for a COVID-19 Booster?
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
DPH Shares Monthly COVID-19 Update, Announces Changes to Data Reporting and Booster Guidance - State of Delaware News
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Real-world data show new Covid boosters increase protection
Let's discuss COVID-19 Bivalent Booster Effectiveness - ICAP
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
